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Abstract: Tissue perfusion is determined by both blood vessel geometry and the rheological properties of blood. Blood is a nonNewtonian fluid, its viscosity being dependent on flow conditions. Blood and plasma viscosities, as well as the rheological properties
of blood cells (e.g., deformability and aggregation of red blood cells), are influenced by disease processes and extreme physiological
conditions. These rheological parameters may in turn affect the blood flow in vessels, and hence tissue perfusion. Unfortunately it
is not always possible to determine if a change in rheological parameters is the cause or the result of a disease process. The
hemorheology-tissue perfusion relationship is further complicated by the distinct in vivo behavior of blood. Besides the special
hemodynamic mechanisms affecting the composition of blood in various regions of the vascular system, autoregulation based on
vascular control mechanisms further complicates this relationship. Hemorheological parameters may be especially important for
adequate tissue perfusion if the vascular system is geometrically challenged.
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Introduction
It is a very basic medical fact that proper tissue/organ
function strongly depends on adequate blood flow.
Obviously, “adequacy” does not denote a steady state
condition, but the ability to match the supply with the
demand of a given tissue. Any disturbance of this delicate
balance results in clinical problems. Higher level living
organisms are well equipped with powerful control
mechanisms to maintain this balance and to keep the
organism in good health, accordingly.

Factors affecting blood flow
Blood flow in the vascular system is determined by the
pressure difference (i.e. perfusion pressure), hydraulic
conductivity of the blood vessels and the fluidity of the
blood. The last 2 factors can be combined into a
resistance parameter (R), yielding a simple relationship
between perfusion pressure (∆P) and blood flow (Q): ∆P
= Q x R. In other words, blood flow under a given
perfusion pressure is inversely proportional to hydraulic

resistance. Adequate blood flow to a given tissue requires
the maintenance of a sufficient pressure gradient across
the tissue that is generated by the heart.
The vascular component of flow resistance is
determined by the geometry of the blood vessels
network. This component is usually called vascular
hindrance (1). Jean-Marie Poiseuille described the
vascular hindrance of a given blood vessel segment as
being directly proportional to the length of the segment
and inversely proportional to the fourth power of the
vessel radius (2), based on his experimental studies. Flow
resistance is also directly proportional to the viscosity of
blood flowing in that segment. This simple relationship is
known since the 19th century; however, under the strong
influence of cellular pathology theory, medical scientists
ignored the role of blood viscosity in flow through a given
vascular network mainly for 3 reasons (3): 1). The fourth
power factor of the blood vessel radius definitely
suppressed the importance of the viscosity factor that is
represented by a power of 1. 2). Static, microscopic
observations of dead, fixed tissues had long been the only
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Despite the efforts of several distinguished medical
scientists (e.g., Robin Fahraeus) (4,5), the importance of
blood rheology (i.e. the flow properties of blood) was not
appreciated during the first 60 years of the 20th century.

Blood rheology as a determinant of blood flow
The role of blood rheology as a determinant of blood
flow and tissue perfusion received considerable attention
with the development of hemorheological theory after
the 1960s. Both the basic science and clinical aspects of
this relationship have been investigated extensively,
together with the unique rheological behavior of blood.
The rheology (i.e. flow behavior) of a fluid can
physically be described by its viscosity. In laminar fluid
flow as described by Newton (6), viscosity is the ratio of
the force that moves the fluid layers or laminae (shear
stress) to the velocity gradient in the fluid (shear rate),
representing internal resistance between the laminae
(6,7). Such a fluid flow can be modeled as flow streamlines moving on a steady surface or, more realistically, as
concentric cylinders moving in the direction of flow in a
cylindrical tube (8).
Blood is a 2-phase liquid. It can be considered a solidliquid suspension if the cellular elements (red blood cells
(RBG), white blood cells (WBCs) and platelets) are
regarded as solid particles. It can also be considered a
liquid-liquid emulsion based on the fluid drop-like
behavior of RBCs under certain conditions (i.e. under high
shear forces) (9). Therefore, depending on the flow
conditions, blood tissue can be regarded as a suspension
or an emulsion. This transition is one of the main reasons
for the special rheological behavior of blood.
Blood is a non-Newtonian, shear thinning fluid (7); its
viscosity is not constant, even with unchanged
composition, and varies as the flow conditions change.
Blood becomes thinner (or more fluid) as the shear forces
that generate flow increase. This is a reversible change
and blood viscosity increases as shear forces get smaller.
The viscosity of blood under a given shear stress is
determined by hematocrit value, plasma viscosity (as the
suspending phase) and the rheological properties of
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RBCs, which constitute 99% of cellular elements (6,7).
WBCs and platelets do not play a significant role in
determining the fluidity of blood under bulk flow
conditions, because of their smaller number, but should
be considered when studying microcirculation (10).
Two special features of RBCs that underlie the nonNewtonian rheological behavior are cellular deformability
and aggregation (11-14). Deformability (i.e. the ability of
the entire cell to reversibly adopt a new shape in response
to deforming forces) is a unique property (13) and partly
contributes to the thinning of blood under high shear
conditions (9,14) by promoting the orientation of RBCs
to the flow streamlines thereby reducing the friction
between them (Figure 1). Aggregation denotes the
formation of reversible clumps of RBCs under sufficiently
low shear stresses (15-17). This behavior tends to
increase the particle size under low shear conditions and
increase the distortion of the flow streamlines (Figure 1),
and hence frictional resistance between them (11).
Therefore, the effect of RBC aggregation is to increase
blood viscosity under smaller shear forces, contributing
to the non-Newtonian behavior. A detailed description of
the mechanisms related to RBC deformability and
aggregation can be found in the literature (18-21); this
topic is outside the scope of this review.
Following the above discussion, it can be stated that
any alterations in the above-mentioned parameters (e.g.,
hematocrit, plasma viscosity, RBC deformability and
aggregation) may result in alterations of blood flow
resistance and tissue perfusion. Unfortunately, the
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basis of medical diagnosis, and functional parameters, like
blood viscosity, have been ignored for a long time. 3).
The viscosity factor was considered a constant, rather
than a variable in the famous Poiseuille equation.
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Figure 1. Shear rate-viscosity curve of normal blood. RBC
deformability reduces the resistance between flow stream
lines at higher shear rates, while the resistance is increased
due to increased RBC aggregation (hence increased particle
size) at lower shear rates.
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interaction between blood rheology factors and
hemodynamic mechanisms are highly complex and the
exact role of blood rheology in physiopathological
processes is still debatable. However, this uncertainty did
not prevent the extensive investigation of
hemorheological parameters under a wide variety of
clinical and experimental conditions.

Alterations in blood rheology
Pathophysiology
Hematocrit value is a dynamic parameter and may
vary depending on the fluid balance of the body. Under
various physiological and/or pathological conditions
hematocrit may reach values high enough to increase
blood viscosity considerably (22). Plasma viscosity is also
sensitive to both general and local homeostasis (23).
RBC deformability is determined by the material
properties, as well as the metabolic status of RBCs.
Various genetic, structural alterations in the cytoplasm
and membrane lead to altered RBC deformability
(13,24). RBC deformability also depends on intact
metabolic pathways and an adequate ATP supply to
support the ion transport systems (25). Failure of these
systems would result in increased intracellular sodium
and calcium concentrations. Impaired sodium exclusion is
the cause of altered fluid-electrolyte balance of this simple
cell and is usually accompanied by alterations in cellular
volume in metabolically depleted RBCs. An increased
cytosolic calcium concentration has been shown to be
related to impaired RBC deformability by affecting the
RBC membrane skeleton (26,27).
It should be noted that such a metabolic depletion
might be the result of a local stasis in an area of impaired
tissue perfusion. Adequate supplies of metabolites to the
RBCs are also required to regenerate several co-factors of
antioxidant mechanisms (e.g., NADH, NADPH) and a lack
of these factors may shift the balance between oxidant
stress and antioxidant defense to yield increased oxidant
damage in RBCs (28). Alternatively, increased generation
of oxidants in ischemic or inflamed tissues may contribute
to this shift. Oxidant damage is a well known cause of
impaired deformability (29). Other alterations in the
micro-environment of RBCs (e.g., change in pH,
osmolarity, temperature) may also affect RBCs’
mechanical properties (13).

RBC aggregation is determined by both plasma and
cellular factors (17). Increased plasma fibrinogen
concentration is one of the main causes of enhanced RBC
aggregation (16). Such an alteration is a common
consequence of acute phase reaction and accompanies
most inflammatory processes yielding enhanced RBC
aggregation (30). Considerable evidence has been
accumulated implying that RBC surface properties also
play significant role in the aggregation process (17,31).
Changes under the influence of metabolic disturbances in
damaged tissues (e.g., increased production of oxidants)
may result in altered RBC aggregation (29).
Clinical considerations
The pathophysiological considerations above are
backed up by a huge number of clinical observations that
can be accessed through specific journals in the field (e.g.,
Biorheology, Clinical Hemorheology and Microcirculation)
and a number of textbooks (32,33). Most of these
observations are based on the measurement of
hemorheological parameters in blood samples outside the
vascular system (i.e. ex vivo). A very brief classified
summary of clinical observations in important disease
categories is presented below.

Cardiovascular diseases
Cardiovascular diseases are among the clinical
conditions with well established hemorheological
consequences. Increased blood viscosity, impaired RBC
deformability and increased RBC aggregation are
reported in a variety of cardiovascular diseases (32).
Among these, peripheral vascular diseases are the most
widely investigated (34). Ischemic diseases of various
organs are known to be associated with hemorheological
impairment (35,36). It should be noted that in all
vascular insufficiencies and ischemic diseases,
hemorheological alterations may result from the
disturbance of local homeostasis as mentioned above.
Therefore, hemorheological alterations in cardiovascular
diseases can easily be considered a result (or an indicator)
of insufficient circulatory function. Alternatively,
alterations in hemorheological parameters may affect
tissue perfusion and be manifested as circulatory
problems.
Hypertension is an interesting example of clinical
disorders characterized by hemorheological alterations.
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Hypertension is a complex pathohphysiological process
(37). Especially the advanced forms of hypertension are
certainly associated with vascular damage and this
damage is claimed to be the cause of hemorheological
alterations. However, impaired hemorheology can also be
expected to be the cause of increased blood pressure, by
contributing to increased peripheral resistance (38).
Recent evidence suggests that altered RBC rheological
properties might be the underlying cause, at least in some
types of hypertension (39).

Diabetes mellitus
Diabetes is another important disease process that is
accompanied
by
generalized
microcirculatory
disturbances. There are a number of studies documenting
increased blood and plasma viscosity, enhanced RBC
aggregation and altered RBC deformability in diabetes
mellitus (40,41). Impaired deformability of
polymorphonuclear leukocytes was also reported in
diabetes and this alteration may also be associated with
tissue perfusion problems (42).

Sepsis syndrome
Sepsis syndrome represents one of the most dramatic
disturbances of the general homeostasis; therefore, it is
not surprising to detect important hemorheological
alterations in sepsis. Both clinical and experimental
studies indicated that sepsis is characterized by
significantly impaired RBC deformability (43-45) and
increased aggregation (46). Such alterations in RBCs may
well contribute to the generalized vascular problems
encountered in sepsis syndrome.

Hematological diseases
Hematological diseases are exceptions in that
hemorheological alterations can easily be identified as the
cause of tissue perfusion problems. Sickle cell disease is
the most striking example in which the dramatic clinical
manifestations can be directly related to the extreme
rheological changes in RBCs containing hemoglobin S
(47,48). Other examples of hematological diseases with
hemorheological
consequences
include
various
hemoglobinopathies (e.g., thalasemia), membrane
protein deficiencies (e.g., band 4.2 deficiency) and
enzyme deficiencies (e.g., glucose-6-phosphate
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deficiency) (49,50). A detailed discussion of the
rheological alterations in hematological problems is
outside the scope of this paper.

Non-clinical conditions
Not only disease processes, but certain extreme
physiological conditions are also characterized by altered
hemorheology. Strenuous exercise has been
demonstrated to have significant effects on blood
rheological parameters (51,52). The effect of exhausting
exercise on RBC deformability was immediate, with a
partial recovery in 15-30 min. There was a late
component of the effect of this exhausting exercise
starting at 60 min; this late effect was characterized by
marked granulocytosis, altered RBC aggregation and
further impairment in RBC deformability. It is quite
possible that these hemorheological alterations play a role
in exercise-related mortality (53). Alternatively, regular
exercise (i.e. training) is known to increase RBC
deformability and decrease blood viscosity, improving the
rheological component of flow resistance. Additionally,
recent evidence suggests that training may reduce the
magnitude of the hemorheological alteration after
exhaustive exercise (52,54), and therefore may have a
protective effect against the expected hemodynamic
extra-load.

The “chicken versus egg” story
The pathophysiological and clinical aspects of
hemorheological alterations summarized above point out
a special feature of blood rheology: alterations in
hemorheological parameters might be the result of local
and/or generalized disturbances in homeostasis. From
another aspect, hemorheological alterations might be
responsible for tissue perfusion problems and consequent
functional deteriorations. It is not always easy to
determine whether the hemorheological alteration is the
cause or the result of a pathophysiological process.
This uncertainty about the exact nature of
hemorheological alteration did not keep the medical
scientists from studying hemorheological alterations in a
very wide range of clinical disorders and extreme
physiological conditions. The development of techniques
to measure hemorheological parameters (e.g., blood and
plasma viscosity, and RBC deformability and aggregation)
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encouraged clinicians to study hemorheological
parameters in blood samples obtained from their
patients. They reported statistically significant
hemorheological alterations in a variety of
pathophysiological conditions.

Pathophysiological significance: Hemorheological
alterations
Hemorheological alterations in various clinical
disorders were statistically significant; however, the
pathophysiological significance of these alterations is
debatable. The main reason for this discrepancy is the
experimentally detected differences between in vivo and
ex vivo (i.e. outside of the vascular network) rheological
behaviors of blood tissue (55,56). Therefore, it is not
possible to apply the results of ex vivo measurements
directly to in vivo flow conditions.
Calculations based on perfusion pressure and blood
flow measurements obtained under real flow conditions
revealed that blood viscosity in vivo is lower than the
value measured ex vivo, using rotational viscometers (3).
The underlying reasons for this difference can be
understood by examining the composition of blood in
various segments of the vascular system. Careful
experimental studies indicated that especially the cellular
content of blood at different levels of circulatory system
varies over a wide range (57-59). This variation is even
true for different positions at the cross-section of a single
blood vessel (60). Particles that can adapt themselves to
hydrodynamic forces (e.g., deformable particles like
RBCs) tend to move to the central regions of tubes, a
more “silent” region in terms of hydrodynamic forces
(61,62). This phenomenon is called axial migration and in
blood vessels results in a plasma-rich zone near the vessel
wall (Figure 2), with relatively lower RBC content (i.e.
lower hematocrit). The side branches of these vessels are
fed by this marginal stream with lower hematocrit
(plasma skimming), leading to significantly lower
hematocrit values in blood vessels smaller than 500 µm in
diameter (tissue hematocrit), compared to samples
obtained from large blood vessels. It has been
demonstrated that mean hematocrit values in these
vessels directly perfusing tissues might be as low as 4050% of systemic hematocrit (58,59). Therefore, the
composition of blood samples obtained from large blood
vessels may not represent the blood in all blood vessels.

Figure 2. Accumulation of RBCs in the central flow zone. Side branches
of this vessel are fed by the plasma-rich zone and have lower
hematocrit values compared to the main vessel (Redrawn
from 3).

The fluid zone closest to the vessel wall has the
greatest contribution to flow resistance, as the frictional
energy loss in this region is maximal (61,62). Frictional
resistance in this zone is determined by the velocity of
fluid layers and viscosity in this region. Decreased RBC
concentration and the related drop in viscosity result in
decreased local hydrodynamic resistance and also affect
general hydrodynamic resistance in the whole vascular
system. Alterations in either plasma composition or in
cellular properties may influence the thickness and
composition of this zone. Increased RBC aggregation was
demonstrated to increase the thickness of this plasmarich zone by increasing the axial migration of RBCs (60).
A series of experimental studies revealed that blood flow
resistance may decrease due to increased RBC
aggregation, especially in low shear rate zones (63-65).
It can be concluded from the above discussion that the
composition, fluidity and contribution to the flow
resistance of blood strongly depend on the flow
conditions and cannot be fully described based on simple
rheological measurements obtained ex vivo.
The contribution of RBC deformability to flow
resistance in vivo is more clearly understood. RBC
deformability may affect flow resistance at various levels
of the circulatory system with different hemodynamic
conditions. Blood viscosity under bulk flow conditions
(i.e. blood flow in large blood vessels) is mainly affected
by the orientation of RBCs to the flow streamlines,
reducing the frictional resistance (viscosity) between
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There is also accumulating evidence for the significant
role
for
WBCs’
rheological
properties
in
pathophysiological processes (68). It is well established
that WBCs’ mechanical properties change extensively
during the activation process of these cells (69,70). It has
been demonstrated that WBCs may significantly affect
microvascular blood flow, despite their relatively small
numbers (68). In contrast, WBCs have no effect on the
rheological properties of blood studied ex vivo.

Pathophysiological significance: Normal versus
geometrically challenged vascular bed
Vascular geometry is the most important determinant
of blood flow in a given vascular network, as described by
J.M. Poiseuille in 19th century. The importance of vascular
geometry is amplified by the fact that blood vessel
diameter is a regulated parameter (71). It is well known
that the diameter of resistance arteries is controlled by
powerful regulatory mechanisms, on one hand
determining the peripheral resistance in the circulatory
system, and on the other hand blood flow to the
microcirculatory
network.
The
adequacy
of
microcirculatory blood flow is the control parameter of
this regulatory mechanism.
Vascular geometry is altered by changing the vascular
smooth muscle tone. The most important determinant of
vascular smooth muscle tone is the metabolic demand of
the perfused tissue (71,72). Any imbalance between the
supplied blood flow and metabolic demands of the tissue
results in altered smooth muscle tone, aiming at
eliminating the imbalance. Therefore, under normal,
physiological conditions any disturbance of the tissue
perfusion resulting from a hemorheological alteration
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(e.g., increased blood viscosity, impaired RBC
deformability) can be corrected by compensatory changes
in vascular hindrance. Obviously, in order to compensate
for a hemorheological extra-load, the vascular network
should be capable of decreasing the vascular hindrance
enough to correct the imbalance introduced by altered
hemorheology. In other words, there should be enough
vasodilatory reserve to maintain sufficient blood flow
with the continuing hemorheological extra-load. Figure 3
indicates that the degree of alteration in flow resistance
with given hemorheological alterations (i.e. impairment in
RBC deformability) strongly depends on the vascular
control mechanisms. In an experiment conducted using an
isolated-perfused rat hind limb preparation it was
demonstrated that the change in flow resistance was
about three fold that of the control in preparations with
paralyzed smooth muscles (73). Based on this
experiment, it can be argued that the degree of tissue
perfusion problem induced by a certain degree of
hemorheological alteration strongly depends on the
vasodilatory reserve (74). Vasodilatory reserve can
frequently be found to be diminished under clinical
conditions and hemorheological alterations may induce
dramatic manifestations under such conditions.
Hemorheological parameters may also affect vascular
control mechanisms by modulating the nitric oxide (NO)
output of endothelium. NO synthesis in endothelial cells is
controlled by a variety of factors including the shear
forces acting on the vessel wall (75). The shear forces
300
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them (12,13). The degree of this orientation is a direct
function of deformability. Flow velocity becomes smaller
as blood moves towards the microcirculation and RBC
aggregation dominates in determining blood fluidity and
flow resistance. However, as the blood approaches blood
vessels with diameters comparable with the size of the
cellular elements, then the ability to adopt a new shape
becomes the only important factor determining the
transit of these elements through microcirculation (66).
However, despite this clear logic behind the role of RBC
deformability in hemodynamics, there is no consensus on
the degree of alteration in deformability that may result
in tissue perfusion problems (67).
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Figure 3. Change in flow resistance (PRU %) plotted against change in
RBC deformability (%) induced by low concentration of
glutaraldehyde, in isolated rat hind limb preparations.
Vascular smooth muscle (SM) was paralyzed with 10-4
papaverin. Data is presented as mean ± standard deviation.
(n=4; *: Difference from control, P < 0.05).
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near the vessel wall are in turn determined by the blood
flow rate and the viscosity of fluid in close contact with
the endothelial cells (76). The composition and the
viscosity of blood in the marginal region of the blood
vessels are known to be influenced by the rheological
properties of blood and blood cells (e.g., RBC
aggregation). It has been demonstrated that chronically
enhanced RBC aggregation results in down regulation of
NO-related control mechanisms of skeletal muscle
resistance arteries in rats (77)).

vivo behavior of blood. This disagreement can be
explained in part by hemodynamic mechanisms such as
the axial migration of RBC, plasma skimming and reduced
tissue hematocrit. However, the detailed understanding
of the role of vascular control mechanisms and especially
the vasodilatory reserve is equally important from a
pathophysiological point of view. Hemorheological
alterations can be well tolerated by these mechanisms, if
there is enough vasodilatory reserve. However, if the
vascular system is geometrically challenged tissue
perfusion problems might be clinically manifested.

Conclusion
The understanding of pathophysiological significance
of blood rheological alterations in disease processes is
seriously challenged by experimental observations that
demonstrate discrepancies between the ex vivo and in
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